首页> 外文期刊>Ultrasound in Medicine and Biology >The preparation of a new self-made microbubble-loading urokinase and its thrombolysis combined with low-frequency ultrasound in vitro.
【24h】

The preparation of a new self-made microbubble-loading urokinase and its thrombolysis combined with low-frequency ultrasound in vitro.

机译:新型自制微泡尿激酶的制备及其溶栓结合低频超声的体外研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Urokinase (uPA) is used widely for thrombosis therapy in the clinic. However, ways to minimize its adverse effect of hemorrhage are still being studied. As a new technique for the local delivery of genes and drugs, ultrasound (US) contrast agents, microbubbles (MBs), have been mentioned. The purpose of this study is to explore a more efficacious and safer thrombolytic method by preparing three groups of self-made microbubble-loading uPA (uPA-MBs) (1 uPA-MBs, 5 uPA-MBs and 10 uPA-MBs) using freeze-drying methods and measuring their thrombolysis when combined in vitro with low-frequency US. The results showed the mean concentration, mean diameter, pH value and encapsulation efficiency of uPA of the three groups of uPA-MBs were approximately 2.08-2.82 x 10(8)/mL, approximately 3.13 mum, 6.89-6.99 and from (78.08% +/- 0.57%) to (57.23% +/- 0.94%), respectively. Under US exposure, the loaded uPA demonstrated bioactivity by agarose fibrin plate and in vitro thrombolysis of the three uPA-MBs also showed higher effects than in the group of those who received uPA-MBs alone, the control group or the US group. In conclusion, the physiochemical properties of these self-made uPA-MBs are suitable for intravenous administration but 1 uPA-MB and 5 uPA-MBs are better than 10 uPA-MBs. uPA-MBs combined with US can decrease the in vitro dosage of uPA for thrombolysis.
机译:尿激酶(uPA)在临床中广泛用于血栓形成治疗。但是,仍在研究使出血的不良影响最小化的方法。作为局部递送基因和药物的新技术,已经提到了超声(US)造影剂,微泡(MB)。这项研究的目的是通过冷冻制备三组自制的微气泡加载uPA(uPA-MB)(1个uPA-MB,5个uPA-MB和10个uPA-MB),以探索一种更有效,更安全的溶栓方法。干燥方法并在体外与低频超声结合时测量其溶栓率。结果显示,三组uPA-MBs的uPA的平均浓度,平均直径,pH值和包封效率分别约为2.08-2.82 x 10(8)/ mL,约3.13妈妈,6.89-6.99和(78.08%)分别为(+/- 0.57%)至(57.23%+/- 0.94%)。在美国暴露下,负载的uPA通过琼脂糖纤维蛋白平板显示出生物活性,并且三个uPA-MB的体外溶栓作用也显示出比单独接受uPA-MB的组,对照组或美国组更高的作用。总之,这些自制的uPA-MB的理化特性适合静脉内给药,但1 uPA-MB和5 uPA-MB优于10 uPA-MB。 uPA-MB与US联用可降低uPA溶栓的体外剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号